Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Revance Therapeutics, Inc. that A Securities Fraud Class Action Lawsuit Has Been FiledNewsfile Corp • 12/28/21
RVNC INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action FiledNewsfile Corp • 12/27/21
RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeutics, Inc.PRNewsWire • 12/25/21
ROSEN, A TOP RANKED LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important February 8 Deadline in Securities Class Action - RVNCPRNewsWire • 12/24/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Fraud Class ActionNewsfile Corp • 12/21/21
Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Revance Therapeutics, Inc. of Securities Class Action Lawsuit and Urges Investors with Significant Losses to Contact the FirmNewsfile Corp • 12/21/21
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Revance Therapeutics, Inc. (RVNC)Business Wire • 12/21/21
RVNC Investor Alert: Thornton Law Firm Alerts Revance Therapeutics Investors of Class Action LawsuitNewsfile Corp • 12/21/21
RVNC Shareholders: Robbins LLP Reminds Investors of Class Action Against Revance Therapeutics, Inc. (RVNC)Business Wire • 12/21/21
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Revance Therapeutics, Inc. (RVNC)Business Wire • 12/20/21
RVNC ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Revance Therapeutics, Inc.Newsfile Corp • 12/18/21
RVNC ALERT: Robbins Geller Rudman & Dowd LLP Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitNewsfile Corp • 12/18/21
Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Revance Therapeutics, Inc.Business Wire • 12/17/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important February 8 Deadline in Securities Class Action – RVNCBusiness Wire • 12/17/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) InvestorsBusiness Wire • 12/16/21
RVNC INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action FiledNewsfile Corp • 12/16/21
Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Revance Therapeutics, Inc. (RVNC)PRNewsWire • 12/16/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) InvestorsBusiness Wire • 12/15/21
RVNC SHAREHOLDERS: Robbins LLP Informs Investors of Class Action Against Revance Therapeutics, Inc. (RVNC)Business Wire • 12/15/21
DEADLINE: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RVNCPRNewsWire • 12/15/21
ROSEN, A LONGSTANDING LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - RVNCPRNewsWire • 12/14/21
RVNC SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action FiledPRNewsWire • 12/14/21
REVANCE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Revance Therapeutics, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 12/14/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Revance Therapeutics, Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - RVNCPRNewsWire • 12/14/21
ALERT: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RVNCBusiness Wire • 12/14/21
